Brief: Implantica Gives Final Response To FDA For PMA Application
20/05/2026 08:15
May 20 (Reuters) - Implantica AG 8IM1q.F: IMPLANTICA SUBMITS FINAL RESPONSE TO FDA IN THE PMA APPLICATION FOR REFLUXSTOP FOR U.S. MARKET APPROVAL SUBMISSION INCLUDES RESPONSES TO FDA QUESTIONS, ADDITIONAL TESTING, AND ALL PMA MODULES SIX FDA PREAPPROVAL INSPECTIONS SUCCESSFULLY CONCLUDED Source text: ID:nWkr3429BP Further company coverage: [8IM1q.F] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3